Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Richard King Mellon Foundation

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 28
Average round size
info
The average size of a deal this fund participated in
$26M
Portfolio companies 26
Rounds per year 0.42
Lead investments 10
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.07
Exits 3
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Education
  • Medical
  • Higher Education
Summary

In 1956 was created Richard King Mellon Foundation, which is appeared as Corporate Investor. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Pittsburgh.

The typical case for the fund is to invest in rounds with 8 participants. Despite the Richard King Mellon Foundation, startups are often financed by Morgenthaler Ventures, Vertex Ventures HC, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Windham Venture Partners, Vertex Ventures HC, Lightstone Ventures. In the next rounds fund is usually obtained by Windham Venture Partners, Vertex Ventures HC, Lightstone Ventures.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 1 or 3 of the founder, the chance for it to be financed is low. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Therapeutics. Among the various public portfolio startups of the fund, we may underline Earlens Corporation, GlobeImmune, Phathom Pharmaceuticals

Comparing to the other companies, this Richard King Mellon Foundation performs on 9 percentage points less the average number of lead investments. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2019. The top activity for fund was in 2019. Considering the real fund results, this Corporate Investor is 0 percentage points less often commits exit comparing to other organizations. The common things for fund are deals in the range of 50 - 100 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Richard King Mellon Foundation:
Typical Co-investors
Richard King Mellon Foundation is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Richard King Mellon Foundation:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AXA Framlington England, London, United Kingdom
China Everbright Ivy Capital Investment -
Duilongyuan Hengchangye Touzi Chengguan District, China, Lhasa
Guangzhou Automobile Industry Group China, Guangdong, Guangzhou
Ireland Strategic Investment Fund County Dublin, Dublin, Ireland
Ningbo Xiao Shizi Touzi Guanli Youxian Gongsi Beijing, Beijing, China
Sanara Ventures HaMerkaz, Israel, Ra'anana
Shenze Chuangy China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Pennsylvania Women Work

Non Profit
$100K13 Jul 2022 Pittsburgh, Pennsylvania, United States

STEM Coding Lab

Education
STEM Education
Underserved Children
$250K26 Apr 2022 Pittsburgh, Pennsylvania, United States

Module

Architecture
Construction
Real Estate
$250K26 Jan 2022 Pittsburgh, Pennsylvania, United States

Meta Mesh

Wireless
$1M10 Jan 2022 Pittsburgh, Pennsylvania, United States

Behaivior

Artificial Intelligence
Health Care
Machine Learning
Software
Wearables
$200K01 Jan 2022 Pittsburgh, Pennsylvania, United States

Carnegie Mellon University - Crunchbase School Profile & Alumni

Higher Education
Universities
$150M18 Nov 2021 Pittsburgh, Pennsylvania, United States

University of Pittsburgh - Crunchbase School Profile & Alumni

Education
Higher Education
Universities
$100M17 Nov 2021 Pittsburgh, Pennsylvania, United States

The Citizen Science Lab

Non Profit
$250K17 Aug 2021 Pittsburgh, Pennsylvania, United States

Health Care
Hospital
$5M10 May 2021 Pittsburgh, Pennsylvania, United States
News
HilleVax Closes $135 Million Crossover Financing to Advance Clinical Stage Norovirus Vaccine Candidate

– HilleVax, Inc. (HilleVax), a biopharmaceutical company focused on the development and commercialization of novel vaccine candidates, announced the close of a $135 million crossover financing led by Frazier Healthcare Partners and joined by RA Capital Management, Deerfield Management Company, Abingworth, Lightspeed Venture Partners, Perceptive Advisors, Catalys Pacific, Samsara BioCapital, BVF Partners, Qiming Venture Partners USA, Greenspring Associates, Richard King Mellon Foundation, and Sahsen Ventures.
– The proceeds of this financing support the further clinical development of HilleVax’s virus-like particle (VLP) based vaccine candidate, HIL-214, for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.

The Citizen Science Lab Receives $250,000 Grant from Richard King Mellon Foundation

– The Citizen Science Lab has been awarded a $250,000 grant from the Richard King Mellon Foundation to expand its work in providing science, technology, engineering and math programs to youth and their families in Pittsburgh.
– A critical component to the creation of a new STEM laboratory located within the Hill District, the funding will play a key role during presentations and negotiations with Hill District stakeholders and community partners to acquire the Dr. Martin Luther King Jr. Reading Center located on 636 Herron Avenue.
– Grant funding provides resources that will allow this project to be molded by input from residents, bringing them even closer to ensuring that The Citizen Science Lab continues to be an anchor institution for STEM enrichment in the Hill District.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Richard King Mellon Foundation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: